Evie Ring (and EvieMED) vs Ultrahuman Ring (Air / Pro) in 2026

Evie Ring (and EvieMED)

Movano Health's Evie Ring is a women's-health-focused smart ring (menstrual-cycle tracking, sleep, energy, heart rate, SpO2, and mood and goal trends; general-wellness, not a diagnostic) and the lifecycle-state-paused archetype of DEPLOY's biometric ring sub-cohort. The verified-vs-claimed distinction is critical: Evie Ring sales are PAUSED, not discontinued.

Following Movano Health's Corvex reverse merger (closed March 19, 2026), an AI-infrastructure pivot, and a 1-for-10 reverse split, the company paused Evie Ring sales while a divestiture of its EvieMED clinical line is pending. EvieMED (the B2B/clinical variant) is an FDA 510(k)-cleared pulse oximeter and heart-rate device (December 2, 2024) for clinical trials, remote patient monitoring, and payors and pharma.

DEPLOY records the consumer Evie Ring at paused availability with no current retail price. Aggregators routinely flatten this as 'Movano discontinued the Evie Ring'; the accurate state is sales-paused amid a corporate pivot, with the EvieMED divestiture pending (an intention where not yet closed). Movano Health trades as NASDAQ: MOVE (CEO John Mastrototaro).

Ultrahuman Ring (Air / Pro)

The Ultrahuman Ring (the Ring Air, plus the Ring Pro that brought a global roughly $349-to-$399 launch around February 2026 with 15-day battery; from Ultrahuman, founded 2019 in Bengaluru by CEO Mohit Kumar and co-founder Vatsal Singhal, with a Plano, Texas factory) is the market-access-redesigned archetype of the ring sub-cohort. Its AI comes via modular 'PowerPlugs' (metabolic and cardio adaptability, circadian rhythm, caffeine window, AFib, cycle), with no mandatory subscription for core tracking and some premium PowerPlugs paid (AFib at about $4.90/month); AFib detection runs through the third-party FibriCheck app, not a native FDA clearance.

The within-entity verified-vs-claimed exemplar is market access, not the product: US market access was blocked on October 21, 2025 under Oura's ITC patent ruling (US Patent 11,868,178), then restored on March 24, 2026 when the Ring Pro's unibody redesign cleared US Customs, a company-availability story that parallels the Apple Watch's disabled-then-restored blood-oxygen feature. The product and AI existed globally throughout; only US market access was interrupted. Price is about $349 (Air) to $399 (Pro), subscription-augmented.